Three Times Daily Dosing of UT-15C
NCT01746485 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2012-12-12
Summary
To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in healthy volunteers
Conditions
- Healthy
Interventions
- DRUG
-
UT-15C
Sponsors & Collaborators
-
United Therapeutics
lead INDUSTRY
Principal Investigators
-
Theresa Pham, MD · PPD Development, LP
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-07-31
Countries
- United States
Study Locations
More Related Trials
-
Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers
NCT02318758 ·Status: COMPLETED ·Phase: PHASE1
-
The Development of Oral Nalbuphine Dosage Form
NCT00924079 ·Status: UNKNOWN ·Phase: NA
-
Dopamine and Muscle Function in the Heat
NCT03515668 ·Status: UNKNOWN ·Phase: NA
-
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
NCT07241065 ·Status: RECRUITING ·Phase: PHASE1
-
Nitrate Supplementation on Motor Unit Activity
NCT05993715 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of PLT Health Solutions zümXR Extended-Release Caffeine
NCT06441695 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Effects of Oral DMAA
NCT01765933 ·Status: COMPLETED ·Phase: NA
-
Acute Caffeine Ingestion on Futsal Performance
NCT04852315 ·Status: COMPLETED ·Phase: NA
-
Role of K+ and Ca2+ in Development of Muscle Fatigue
NCT02712658 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects
NCT01934166 ·Status: COMPLETED ·Phase: PHASE1
-
Beta2-adrenergic Agonism and Muscle Remodelling
NCT03565302 ·Status: UNKNOWN ·Phase: NA
-
Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers
NCT01774994 ·Status: COMPLETED ·Phase: NA
-
Energy Drinks & Driving Ability
NCT01007877 ·Status: COMPLETED ·Phase: NA
-
The Effects of Caffeine on Pain-Based Pacing During a Cycling Time-Trial
NCT02115763 ·Status: COMPLETED ·Phase: PHASE1
-
Nitrate Supplementation; Duration
NCT02115893 ·Status: COMPLETED ·Phase: PHASE4
-
A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects
NCT05672667 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Stimulant Medications Infusion Through Midline Catheters Based on Real-world Data
NCT06454552 ·Status: NOT_YET_RECRUITING
-
Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation
NCT03777605 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects
NCT02259985 ·Status: COMPLETED ·Phase: PHASE1
-
Thebaine Urine Testing
NCT07192887 ·Status: RECRUITING
-
The Role of Methylphenidate on Performance in the Cold
NCT04283877 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetics of the Basel Phenotyping Cocktail Combination Capsule
NCT03247699 ·Status: COMPLETED ·Phase: NA
-
Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers
NCT00785460 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Nitrite and Nitrate in Healthy Normal Volunteer Adults
NCT01681836 ·Status: COMPLETED ·Phase: PHASE1
-
Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler
NCT04856098 ·Status: COMPLETED ·Phase: PHASE1